US Foods Reports First Quarter Fiscal Year 2022 Earnings
US Foods Holding Corp. (USFD) reported its Q1 fiscal 2022 results, showcasing a 23.9% increase in net sales, reaching $7.8 billion. Total case volume rose 4.1%, driven by a 9.2% increase in independent restaurant case volume. Gross profit grew 19.1% to $1.2 billion, with an adjusted EBITDA increase of 40.1% to $241 million. Despite a net loss of $16 million, improved from the prior year, adjusted diluted EPS was $0.36. The company aims to bolster growth and operational efficiencies amid ongoing industry challenges.
- Net sales increased by 23.9% to $7.8 billion.
- Gross profit rose by 19.1%, totaling $1.2 billion.
- Adjusted EBITDA grew by 40.1% to $241 million.
- Independent restaurant case volume increased by 9.2%.
- Net loss available to common shareholders was $16 million.
- Operating expenses increased by 19.1% to $1.2 billion.
First Quarter Fiscal 2022 Highlights
-
Total case volume increased
4.1% versus the same period in fiscal year 2021; independent restaurant case volume increased9.2% versus the same period in fiscal year 2021 -
Net sales increased
23.9% to$7.8 billion -
Gross profit increased
19.1% to$1.2 billion -
Net loss available to common shareholders improved to
$16 million -
Adjusted EBITDA increased
40.1% to$241 million -
Diluted EPS loss was
; Adjusted Diluted EPS1 was$0.07 $0.36
Leadership Perspective
“Our results this quarter are a promising affirmation of our progress in implementing our long-range plan to profitably grow market share, further optimize gross margins and improve operational efficiencies,” said Executive Chairman
Interim CEO
First Quarter Fiscal 2022 Results
Total case volume increased
Gross profit was
Operating expenses of
Adjusted EBITDA was
Cash Flow and Debt
Cash flow provided by operating activities in the first quarter of fiscal 2022 was
Net Debt at the end of the first quarter of fiscal 2022 was
Outlook for Fiscal Year 20222
The Company reaffirms the fiscal year 2022 guidance provided on
___________________________
1 Due to the expected Net loss reported in Q1 FY22 and the Net loss reported in Q1 FY21, the company’s share count for its Adjusted Diluted EPS calculation for these quarters does not assume conversion of the outstanding Series A preferred stock, held by KKR, into 24.8 million shares of common stock. |
2 The Company is not providing a reconciliation of certain forward-looking non-GAAP financial measures, including Adjusted EBITDA and Adjusted Diluted EPS, because the Company is unable to predict with reasonable certainty the financial impact of certain significant items, including restructuring costs and asset impairment charges, share-based compensation expenses, non-cash impacts of LIFO reserve adjustments, losses on extinguishments of debt, business transformation costs, other gains and losses, business acquisition and integration related costs and diluted earnings per share. These items are uncertain, depend on various factors, and could have a material impact on GAAP reported results for the guidance periods. For the same reasons, the Company is unable to address the significance of the unavailable information, which could be material to future results. |
Conference Call and Webcast Information
About
With a promise to help its customers Make It,
Forward-Looking Statements
Statements in this press release which are not historical in nature, including those under the heading “Outlook for Fiscal Years 2022 and 2024,” are “forward-looking statements” within the meaning of the federal securities laws. These statements often include words such as “believe,” “expect,” “project,” “anticipate,” “intend,” “plan,” “outlook,” “estimate,” “target,” “seek,” “will,” “may,” “would,” “should,” “could,” “forecast,” “mission,” “strive,” “more,” “goal,” or similar expressions (although not all forward-looking statements may contain such words) and are based upon various assumptions and our experience in the industry, as well as historical trends, current conditions, and expected future developments. However, you should understand that these statements are not guarantees of performance or results and there are a number of risks, uncertainties and other important factors that could cause our actual results to differ materially from those expressed in the forward-looking statements, including, among others: economic factors affecting consumer confidence and discretionary spending and reducing the consumption of food prepared away from home; the extent and duration of the negative impact of the COVID-19 pandemic on us; cost inflation/deflation and commodity volatility; competition; reliance on third party suppliers and interruption of product supply or increases in product costs; changes in our relationships with customers and group purchasing organizations; our ability to increase or maintain the highest margin portions of our business; achievement of expected benefits from cost savings initiatives; increases in fuel costs; changes in consumer eating habits; cost and pricing structures; impairment charges for goodwill, indefinite-lived intangible assets or other long-lived assets; environmental, health and safety and other governmental regulation, including actions taken by national, state and local governments to contain the COVID-19 pandemic, such as travel restrictions or bans, social distancing requirements, and required closures of non-essential businesses; product recalls and product liability claims; our reputation in the industry; indebtedness and restrictions under agreements governing our indebtedness; interest rate increases; changes in the method of determining London Interbank Offered Rate (“LIBOR”) or the replacement of LIBOR with an alternative reference rate; labor relations and increased labor costs and continued access to qualified and diverse labor; risks associated with intellectual property, including potential infringement; disruption of existing technologies and implementation of new technologies; cybersecurity incidents and other technology disruptions; effective integration of acquired businesses; changes in tax laws and regulations and resolution of tax disputes; adverse judgments or settlements resulting from litigation; extreme weather conditions, natural disasters and other catastrophic events, including pandemics and the rapid spread of contagious illnesses; costs and risks associated with current and changing government laws and regulations, and potential changes as a result of initiatives by the Biden administration; management of retirement benefits and pension obligations; and potential costs associated with shareholder activism.
For a detailed discussion of these risks, uncertainties and other factors that could cause our results to differ materially from those anticipated or expressed in any forward-looking statements, see the section entitled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended
Non-GAAP Financial Measures
We report our financial results in accordance with
We use Adjusted Gross profit and Adjusted Operating expenses as supplemental measures to GAAP measures to focus on period-over-period changes in our business and believe this information is helpful to investors. Adjusted Gross profit is Gross profit adjusted to remove the impact of the LIFO inventory reserve adjustments. Adjusted Operating expenses are Operating expenses adjusted to exclude amounts that we do not consider part of our core operating results when assessing our performance.
We believe EBITDA and Adjusted EBITDA provide meaningful supplemental information about our operating performance because they exclude amounts that we do not consider part of our core operating results when assessing our performance. EBITDA is Net income (loss), plus Interest expense-net, Income tax provision (benefit), and Depreciation and amortization. Adjusted EBITDA is EBITDA adjusted for (1) Restructuring costs and asset impairment charges; (2) Share-based compensation expense; (3) the non-cash impact of LIFO reserve adjustments; (4) loss on extinguishment of debt; (5) Business transformation costs; and (6) other gains, losses or costs as specified in the agreements governing our indebtedness.
We use Net Debt and Net Leverage Ratio as supplemental measures to GAAP measures to review the liquidity of our operations. Net Debt is defined as total debt net of total Cash, cash equivalents and restricted cash remaining on the balance sheet as of the end of the most recent fiscal quarter. Net Leverage Ratio represents Net Debt divided by Trailing Twelve Months Adjusted EBITDA. We believe that Net Debt and Net Leverage Ratio are useful financial metrics to assess our ability to pursue business opportunities and investments. Net Debt is not a measure of our liquidity under GAAP and should not be considered as an alternative to Cash Flows Provided by Operations or Cash Flows Used in Financing Activities.
We believe that Adjusted Net income (loss) is a useful measure of operating performance for both management and investors because it excludes items that are not reflective of our core operating performance and provides an additional view of our operating performance including depreciation, interest expense, and Income taxes on a consistent basis from period to period. Adjusted Net income (loss) is Net income (loss) excluding such items as restructuring costs and asset impairment charges, Share-based compensation expense, the non-cash impacts of LIFO reserve adjustments, loss on extinguishment of debt, Business transformation costs and other items, and adjusted for the tax effect of the exclusions and discrete tax items. We believe that Adjusted Net income (loss) may be used by investors, analysts, and other interested parties to facilitate period-over-period comparisons and provides additional clarity as to how factors and trends impact our operating performance.
We use Adjusted Diluted Earnings per Share, which is calculated by adjusting the most directly comparable GAAP financial measure, Diluted Earnings per Share, by excluding the same items excluded in our calculation of Adjusted EBITDA to the extent that each such item was included in the applicable GAAP financial measure. We believe the presentation of Adjusted Diluted Earnings per Share is useful to investors because the measurement excludes amounts that we do not consider part of our core operating results when assessing our performance. We also believe that the presentation of Adjusted EBITDA and Adjusted Diluted Earnings per Share is useful to investors because these metrics may be used by securities analysts, investors and other interested parties in their evaluation of the operating performance of companies in our industry.
Management uses these non-GAAP financial measures (a) to evaluate our historical and prospective financial performance as well as our performance relative to our competitors as they assist in highlighting trends, (b) to set internal sales targets and spending budgets, (c) to measure operational profitability and the accuracy of forecasting, (d) to assess financial discipline over operational expenditures, and (e) as an important factor in determining variable compensation for management and employees. EBITDA and Adjusted EBITDA are also used in connection with certain covenants and restricted activities under the agreements governing our indebtedness. We also believe these and similar non-GAAP financial measures are frequently used by securities analysts, investors, and other interested parties to evaluate companies in our industry.
We caution readers that our definitions of Adjusted Gross profit, Adjusted Operating expenses, EBITDA, Adjusted EBITDA, Adjusted Net income (loss), Adjusted Diluted EPS, Net Debt and Net Leverage Ratio may not be calculated in the same manner as similar measures used by other companies. Definitions and reconciliations of the non-GAAP financial measures to their most comparable GAAP financial measures are included in the schedules attached to this press release.
Source:
|
||||||||
Consolidated Balance Sheets |
||||||||
(Unaudited) |
||||||||
($ in millions) |
|
|
|
|
||||
|
|
|
|
|
||||
ASSETS |
|
|
|
|
||||
Current assets: |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
190 |
|
|
$ |
148 |
|
Accounts receivable, less allowances of |
|
|
1,658 |
|
|
|
1,469 |
|
Vendor receivables, less allowances of |
|
|
199 |
|
|
|
145 |
|
Inventories—net |
|
|
1,826 |
|
|
|
1,686 |
|
Prepaid expenses |
|
|
148 |
|
|
|
120 |
|
Assets held for sale |
|
|
8 |
|
|
|
8 |
|
Other current assets |
|
|
21 |
|
|
|
18 |
|
Total current assets |
|
|
4,050 |
|
|
|
3,594 |
|
Property and equipment—net |
|
|
2,022 |
|
|
|
2,033 |
|
|
|
|
5,625 |
|
|
|
5,625 |
|
Other intangibles—net |
|
|
819 |
|
|
|
830 |
|
Deferred tax assets |
|
|
9 |
|
|
|
8 |
|
Other assets |
|
|
435 |
|
|
|
431 |
|
Total assets |
|
$ |
12,960 |
|
|
$ |
12,521 |
|
|
|
|
|
|
||||
LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ EQUITY |
|
|
|
|
||||
Current liabilities: |
|
|
|
|
||||
Cash overdraft liability |
|
$ |
214 |
|
|
$ |
183 |
|
Accounts payable |
|
|
2,077 |
|
|
|
1,662 |
|
Accrued expenses and other current liabilities |
|
|
635 |
|
|
|
610 |
|
Current portion of long-term debt |
|
|
103 |
|
|
|
95 |
|
Total current liabilities |
|
|
3,029 |
|
|
|
2,550 |
|
Long-term debt |
|
|
4,890 |
|
|
|
4,916 |
|
Deferred tax liabilities |
|
|
312 |
|
|
|
307 |
|
Other long-term liabilities |
|
|
473 |
|
|
|
479 |
|
Total liabilities |
|
|
8,704 |
|
|
|
8,252 |
|
Mezzanine equity: |
|
|
|
|
||||
Series A convertible preferred stock |
|
|
534 |
|
|
|
534 |
|
Shareholders’ equity: |
|
|
|
|
||||
Common stock |
|
|
2 |
|
|
|
2 |
|
Additional paid-in capital |
|
|
2,973 |
|
|
|
2,970 |
|
Retained earnings |
|
|
766 |
|
|
|
782 |
|
Accumulated other comprehensive loss |
|
|
(19 |
) |
|
|
(19 |
) |
Total shareholders’ equity |
|
|
3,722 |
|
|
|
3,735 |
|
Total liabilities, mezzanine equity and shareholders’ equity |
|
$ |
12,960 |
|
|
$ |
12,521 |
|
|
|||||||
Consolidated Statements of Operations |
|||||||
(Unaudited) |
|||||||
|
13 Weeks Ended |
||||||
($ in millions, except share and per share data) |
|
|
|
||||
Net sales |
$ |
7,798 |
|
|
$ |
6,295 |
|
Cost of goods sold |
|
6,603 |
|
|
|
5,292 |
|
Gross profit |
|
1,195 |
|
|
|
1,003 |
|
Operating expenses: |
|
|
|
||||
Distribution, selling and administrative costs |
|
1,161 |
|
|
|
972 |
|
Restructuring costs and asset impairment charges |
|
— |
|
|
|
3 |
|
Total operating expenses |
|
1,161 |
|
|
|
975 |
|
Operating income |
|
34 |
|
|
|
28 |
|
Other income—net |
|
(6 |
) |
|
|
(7 |
) |
Interest expense—net |
|
55 |
|
|
|
54 |
|
Loss on extinguishment of debt |
|
— |
|
|
|
23 |
|
Loss before income taxes |
|
(15 |
) |
|
|
(42 |
) |
Income tax benefit |
|
(8 |
) |
|
|
(18 |
) |
Net loss |
$ |
(7 |
) |
|
$ |
(24 |
) |
|
|
|
|
||||
Net loss |
$ |
(7 |
) |
|
$ |
(24 |
) |
Series A convertible preferred stock dividends |
|
(9 |
) |
|
|
(15 |
) |
Net loss available to common shareholders |
$ |
(16 |
) |
|
$ |
(39 |
) |
|
|
|
|
||||
Net loss per share |
|
|
|
||||
Basic |
$ |
(0.07 |
) |
|
$ |
(0.18 |
) |
Diluted |
$ |
(0.07 |
) |
|
$ |
(0.18 |
) |
|
|
|
|
||||
Weighted-average common shares outstanding |
|
|
|
||||
Basic |
|
222,877,385 |
|
|
|
220,713,683 |
|
Diluted |
|
222,877,385 |
|
|
|
220,713,683 |
|
|
|
|
|
|
||||||||
Consolidated Statements of Cash Flows |
||||||||
(Unaudited) |
||||||||
|
|
13 Weeks Ended |
||||||
($ in millions) |
|
|
|
|
||||
Cash flows from operating activities: |
|
|
|
|
||||
Net loss |
|
$ |
(7 |
) |
|
$ |
(24 |
) |
Adjustments to reconcile net loss to net cash provided by operating activities: |
|
|
|
|
||||
Depreciation and amortization |
|
|
89 |
|
|
|
101 |
|
Gain on disposal of property and equipment—net |
|
|
(1 |
) |
|
|
— |
|
Loss on extinguishment of debt |
|
|
— |
|
|
|
23 |
|
Amortization of deferred financing costs |
|
|
3 |
|
|
|
3 |
|
Deferred tax provision (benefit) |
|
|
4 |
|
|
|
(4 |
) |
Share-based compensation expense |
|
|
12 |
|
|
|
10 |
|
Provision (benefit) for doubtful accounts |
|
|
— |
|
|
|
(12 |
) |
Changes in operating assets and liabilities: |
|
|
|
|
||||
Increase in receivables |
|
|
(243 |
) |
|
|
(315 |
) |
Increase in inventories—net |
|
|
(140 |
) |
|
|
(178 |
) |
Increase in prepaid expenses and other assets |
|
|
(37 |
) |
|
|
(25 |
) |
Increase in accounts payable and cash overdraft liability |
|
|
463 |
|
|
|
555 |
|
Increase in accrued expenses and other liabilities |
|
|
15 |
|
|
|
42 |
|
Net cash provided by operating activities |
|
|
158 |
|
|
|
176 |
|
Cash flows from investing activities: |
|
|
|
|
||||
Proceeds from sales of property and equipment |
|
|
2 |
|
|
|
— |
|
Purchases of property and equipment |
|
|
(72 |
) |
|
|
(46 |
) |
Net cash used in investing activities |
|
|
(70 |
) |
|
|
(46 |
) |
Cash flows from financing activities: |
|
|
|
|
||||
Proceeds from debt borrowings |
|
|
103 |
|
|
|
900 |
|
Principal payments on debt and financing leases |
|
|
(131 |
) |
|
|
(926 |
) |
Dividends paid on Series A convertible preferred stock |
|
|
(9 |
) |
|
|
— |
|
Debt financing costs and fees |
|
|
— |
|
|
|
(18 |
) |
Proceeds from employee stock purchase plan |
|
|
5 |
|
|
|
5 |
|
Proceeds from exercise of stock options |
|
|
2 |
|
|
|
4 |
|
Tax withholding payments for net share-settled equity awards |
|
|
(16 |
) |
|
|
(12 |
) |
Net cash used in financing activities |
|
|
(46 |
) |
|
|
(47 |
) |
Net increase in cash, and cash equivalents and restricted cash |
|
|
42 |
|
|
|
83 |
|
Cash, cash equivalents and restricted cash—beginning of period |
|
|
148 |
|
|
|
829 |
|
Cash, cash equivalents and restricted cash—end of period |
|
$ |
190 |
|
|
$ |
912 |
|
Supplemental disclosures of cash flow information: |
|
|
|
|
||||
Interest paid—net of amounts capitalized |
|
$ |
37 |
|
|
$ |
33 |
|
Income taxes paid—net |
|
|
1 |
|
|
|
— |
|
Property and equipment purchases included in accounts payable |
|
|
29 |
|
|
|
23 |
|
Property and equipment transferred to assets held for sale |
|
|
— |
|
|
|
9 |
|
Leased assets obtained in exchange for financing lease liabilities |
|
|
7 |
|
|
|
7 |
|
Leased assets obtained in exchange for operating lease liabilities |
|
|
7 |
|
|
|
8 |
|
Cashless exercise of stock options |
|
|
1 |
|
|
|
— |
|
Paid-in-kind Series A convertible preferred stock dividends |
|
|
— |
|
|
|
15 |
|
|
|||||||||||||||
Non-GAAP Reconciliation |
|||||||||||||||
(Unaudited) |
|||||||||||||||
|
|
13 Weeks Ended |
|
|
|
|
|||||||||
($ in millions, except share and per share data) |
|
|
|
|
|
Change |
|
% |
|||||||
Net loss available to common shareholders (GAAP) |
|
$ |
(16 |
) |
|
$ |
(39 |
) |
|
$ |
23 |
|
|
(59.0 |
)% |
Series A Preferred Stock Dividends |
|
|
(9 |
) |
|
|
(15 |
) |
|
|
6 |
|
|
(40.0 |
)% |
Net loss (GAAP) |
|
|
(7 |
) |
|
|
(24 |
) |
|
|
17 |
|
|
(70.8 |
)% |
Interest expense—net |
|
|
55 |
|
|
|
54 |
|
|
|
1 |
|
|
1.9 |
% |
Income tax benefit |
|
|
(8 |
) |
|
|
(18 |
) |
|
|
10 |
|
|
(55.6 |
)% |
Depreciation expense |
|
|
78 |
|
|
|
82 |
|
|
|
(4 |
) |
|
(4.9 |
)% |
Amortization expense |
|
|
11 |
|
|
|
19 |
|
|
|
(8 |
) |
|
(42.1 |
)% |
EBITDA (Non-GAAP) |
|
|
129 |
|
|
|
113 |
|
|
|
16 |
|
|
14.2 |
% |
Adjustments: |
|
|
|
|
|
|
|
|
|||||||
Restructuring costs and asset impairment charges (1) |
|
|
— |
|
|
|
3 |
|
|
|
(3 |
) |
|
(100.0 |
)% |
Share-based compensation expense (2) |
|
|
12 |
|
|
|
10 |
|
|
|
2 |
|
|
20.0 |
% |
LIFO reserve adjustment (3) |
|
|
72 |
|
|
|
21 |
|
|
|
51 |
|
|
242.9 |
% |
Loss on extinguishment of debt (4) |
|
|
— |
|
|
|
23 |
|
|
|
(23 |
) |
|
(100.0 |
)% |
Business transformation costs (5) |
|
|
14 |
|
|
|
9 |
|
|
|
5 |
|
|
55.6 |
% |
COVID-19 bad debt benefit (6) |
|
|
— |
|
|
|
(15 |
) |
|
|
15 |
|
|
(100.0 |
)% |
Business acquisition and integration related costs and other (7) |
|
|
14 |
|
|
|
8 |
|
|
|
6 |
|
|
75.0 |
% |
Adjusted EBITDA (Non-GAAP) |
|
|
241 |
|
|
|
172 |
|
|
|
69 |
|
|
40.1 |
% |
Depreciation expense |
|
|
(78 |
) |
|
|
(82 |
) |
|
|
4 |
|
|
(4.9 |
)% |
Interest expense—net |
|
|
(55 |
) |
|
|
(54 |
) |
|
|
(1 |
) |
|
1.9 |
% |
Income tax provision, as adjusted (8) |
|
|
(28 |
) |
|
|
(9 |
) |
|
|
(19 |
) |
|
211.1 |
% |
Adjusted Net Income (Non-GAAP) |
|
$ |
80 |
|
|
$ |
27 |
|
|
$ |
53 |
|
|
196.3 |
% |
|
|
|
|
|
|
|
|
|
|||||||
Diluted EPS (GAAP) |
|
$ |
(0.07 |
) |
|
$ |
(0.18 |
) |
|
$ |
0.11 |
|
|
(61.1 |
)% |
Restructuring costs and asset impairment charges (1) |
|
|
— |
|
|
|
0.01 |
|
|
|
(0.01 |
) |
|
(100.0 |
)% |
Share-based compensation expense (2) |
|
|
0.05 |
|
|
|
0.05 |
|
|
|
— |
|
|
— |
% |
LIFO reserve adjustment (3) |
|
|
0.32 |
|
|
|
0.10 |
|
|
|
0.22 |
|
|
220.0 |
% |
Loss on extinguishment of debt (4) |
|
|
— |
|
|
|
0.10 |
|
|
|
(0.10 |
) |
|
(100.0 |
) % |
Business transformation costs (5) |
|
|
0.06 |
|
|
|
0.04 |
|
|
|
0.02 |
|
|
50.0 |
% |
COVID-19 bad debt benefit (6) |
|
|
— |
|
|
|
(0.07 |
) |
|
|
0.07 |
|
|
(100.0 |
)% |
Business acquisition and integration related costs and other (7) |
|
|
0.06 |
|
|
|
0.04 |
|
|
|
0.02 |
|
|
50.0 |
% |
Income tax provision, as adjusted (8) |
|
|
(0.06 |
) |
|
|
0.03 |
|
|
|
(0.09 |
) |
|
NM |
|
Adjusted Diluted EPS (Non-GAAP) (9) |
|
$ |
0.36 |
|
|
$ |
0.12 |
|
|
$ |
0.24 |
|
|
200.0 |
% |
|
|
|
|
|
|
|
|
|
|||||||
Weighted-average diluted shares outstanding (Non-GAAP) (10) |
|
|
222,877,385 |
|
|
|
220,713,683 |
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|||||||
Gross profit (GAAP) |
|
$ |
1,195 |
|
|
$ |
1,003 |
|
|
$ |
192 |
|
|
19.1 |
% |
LIFO reserve change (3) |
|
|
72 |
|
|
|
21 |
|
|
|
51 |
|
|
242.9 |
% |
Adjusted Gross profit (Non-GAAP) |
|
$ |
1,267 |
|
|
$ |
1,024 |
|
|
$ |
243 |
|
|
23.7 |
% |
|
|
|
|
|
|
|
|
|
|||||||
Operating expenses (GAAP) |
|
$ |
1,161 |
|
|
$ |
975 |
|
|
$ |
186 |
|
|
19.1 |
% |
Depreciation expense |
|
|
(78 |
) |
|
|
(82 |
) |
|
|
4 |
|
|
(4.9 |
)% |
Amortization expense |
|
|
(11 |
) |
|
|
(19 |
) |
|
|
8 |
|
|
(42.1 |
)% |
Restructuring costs and asset impairment charges (1) |
|
|
— |
|
|
|
(3 |
) |
|
|
3 |
|
|
(100.0 |
)% |
Share-based compensation expense (2) |
|
|
(12 |
) |
|
|
(10 |
) |
|
|
(2 |
) |
|
20.0 |
% |
Business transformation costs (5) |
|
|
(14 |
) |
|
|
(9 |
) |
|
|
(5 |
) |
|
55.6 |
% |
COVID-19 bad debt benefit (6) |
|
|
— |
|
|
|
15 |
|
|
|
(15 |
) |
|
(100.0 |
)% |
Business acquisition and integration related costs and other (7) |
|
|
(14 |
) |
|
|
(8 |
) |
|
|
(6 |
) |
|
75.0 |
% |
Adjusted Operating expenses (Non-GAAP) |
|
$ |
1,032 |
|
|
$ |
859 |
|
|
$ |
173 |
|
|
20.1 |
% |
NM - Not Meaningful |
||
(1) |
Consists primarily of severance and related costs, organizational realignment costs and asset impairment charges. |
|
(2) |
Share-based compensation expense for expected vesting of stock awards and employee stock purchase plan. |
|
(3) |
Represents the non-cash impact of LIFO reserve adjustments. |
|
(4) |
Includes early redemption premium and the write-off of certain pre-existing debt issuance costs. |
|
(5) |
Consists primarily of costs related to significant process and systems redesign across multiple functions. |
|
(6) |
Includes the changes in the reserve for doubtful accounts expense reflecting the collection risk associated with our customer base as a result of the COVID-19 pandemic. |
|
(7) |
Includes: (i) aggregate acquisition and integration related costs of |
|
(8) |
Represents our income tax provision (benefit) adjusted for the tax effect of pre-tax items excluded from Adjusted net income and the removal of applicable discrete tax items. Applicable discrete tax items include changes in tax laws or rates, changes related to prior year unrecognized tax benefits, discrete changes in valuation allowances, and excess tax benefits associated with share-based compensation. The tax effect of pre-tax items excluded from Adjusted net income is computed using a statutory tax rate after taking into account the impact of permanent differences and valuation allowances. |
|
(9) |
Adjusted Diluted EPS is calculated as Adjusted net income divided by weighted average diluted shares outstanding (Non-GAAP). |
|
(10) |
For purposes of the Adjusted Diluted EPS calculation (Non-GAAP), when the Company has net income (GAAP), weighted average diluted shares outstanding (Non-GAAP) is used and assumes conversion of the Series A convertible preferred stock, and, when the Company has net loss (GAAP) and assumed conversion of the Series A convertible preferred stock would be antidilutive, weighted-average diluted shares outstanding (GAAP) is used. |
|
||||||||||||
Non-GAAP Reconciliation |
||||||||||||
Net Debt and Net Leverage Ratios |
||||||||||||
($ in millions, except ratios) |
|
|
|
|
|
|
||||||
Total Debt (GAAP) |
|
$ |
4,993 |
|
|
$ |
5,011 |
|
|
$ |
5,738 |
|
Cash, cash equivalents and restricted cash |
|
|
(190 |
) |
|
|
(148 |
) |
|
|
(912 |
) |
Net Debt (Non-GAAP) |
|
$ |
4,803 |
|
|
$ |
4,863 |
|
|
$ |
4,826 |
|
Adjusted EBITDA (1) |
|
$ |
1,126 |
|
|
$ |
1,057 |
|
|
$ |
643 |
|
Net Leverage Ratio (2) |
|
|
4.3 |
|
|
|
4.6 |
|
|
|
7.5 |
|
(1) Trailing Twelve Months (TTM) Adjusted EBITDA |
||||||||||||
(2) Net Debt/TTM Adjusted EBITDA |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220511005991/en/
INVESTOR CONTACT:
(847) 720-8109
Snehal.Shah@usfoods.com
MEDIA CONTACT:
(847) 720-2392
Sara.Matheu@usfoods.com
Source:
FAQ
What were US Foods' (USFD) total net sales for Q1 2022?
How did US Foods' gross profit change in Q1 2022?
What is the adjusted EBITDA for US Foods in Q1 2022?